Conclusions: Statins may reduce airway inflammation in asthmatics, without having a significant effect on lung function. Further large sample and multicenter clinical trials are needed to confirm this and to see if there are more responsive phenotypes of asthma.
Quiera el lector descargar el artículo o leer online:
- COPD: 3 Biomarkers Linked to Exacerbation Risk
- Cystic Fibrosis: New Assay May Help Individualize Care
- Childhood Asthma Raises Risk for Adult Sleep Apnea
- Azithromycin May Prolong Time to Rehospitalization in COPD
- EZ Breathe Atomizer Subject of Class 1 Recall
Respiratory Research. 2012;13(108) © 2012 BioMed Central, Ltd.
No hay comentarios:
Publicar un comentario